Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Neurología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 4
ClinicalTrials.gov
A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Evaluation of Lamotrigine Adjunctive Therapy in Subjects Wtih Primary Generalized Tonic-Clonic Seizures
INTERVENTIONAL
Inicio: 1 de dic de 2000
ID: NCT00043901
Por invitación
Fase 3
ClinicalTrials.gov
A Phase 3, Single-Arm, Multicenter, Open-label Extension of Study ARGX-113-2007 to Investigate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Participants Aged 18 Years and Older With Active Idiopathic Inflammatory Myopathy
INTERVENTIONAL
Inicio: 12 de sept de 2023
ID: NCT05979441
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Multi-center Phase III Study Comparing Everolimus (RAD001) Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in Patients With Advanced Gastric Cancer After Progression on 1 or 2 Prior Systemic Chemotherapy
INTERVENTIONAL
Inicio: 1 de jul de 2009
ID: NCT00879333
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Randomised, Double-blind, Multicentre, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Dolutegravir Plus Lamivudine Compared to Dolutegravir Plus Tenofovir/Emtricitabine in HIV-1-infected Treatment-naïve Adults
INTERVENTIONAL
Inicio: 18 de jul de 2016
ID: NCT02831764
Por invitación
Fase 3
ClinicalTrials.gov
A Long-term Extension Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Subcutaneous Amlitelimab in Participants of Previous Amlitelimab Clinical Trials in Moderate to Severe Atopic Dermatitis.
INTERVENTIONAL
Inicio: 22 de ago de 2022
ID: NCT05492578
Completado
ClinicalTrials.gov
Trial Clínico: Utilidad Del Telemonitoreo en Pacientes Con IC Como Medio de Apoyo Para la autogestión de la Enfermedad
INTERVENTIONAL
Inicio: 1 de ago de 2018
ID: NCT04437849
Terminado
ClinicalTrials.gov
48-hour Versus 7-day Monitoring for the Detection of Atrial Fibrillation in Patients with Cryptogenic Stroke
INTERVENTIONAL
Inicio: 2 de nov de 2020
ID: NCT04644679
Completado
Fase 3
ClinicalTrials.gov
A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy and to Determine the Pharmacokinetics of Two Doses of AVP-923 (Dextromethorphan/Quinidine) in the Treatment of Pseudobulbar Affect (PBA) in Patients With Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis (MS)
INTERVENTIONAL
Inicio: 1 de dic de 2007
ID: NCT00573443
Terminado
Fase 3
ClinicalTrials.gov
A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis
INTERVENTIONAL
Inicio: 8 de jul de 2016
ID: NCT02660359
Completado
Fase 4
ClinicalTrials.gov
Prospective, Randomized, Open-label, Blinded Endpoint, Forced Titration Study to Compare Telmisartan Combined With HCTZ (80mg/12.5mg), to Valsartan Combined With HCTZ (160mg/12.5mg), for the Control of Mild-to-moderate Hypertension in Obese Patients With Type 2 Diabetes Mellitus Using ABPM.
INTERVENTIONAL
Inicio: 1 de ene de 2003
ID: NCT00239538
Completado
ClinicalTrials.gov
pToWin pCONus Treatment of Wide Neck Intracranial Aneurysms
OBSERVATIONAL
Inicio: 1 de ago de 2015
ID: NCT02554708
Terminado
Fase 3
ClinicalTrials.gov
Phase 3 Multi Center, Double Blind, Randomized, Placebo Controlled, Parallel Group Evaluation Of The Efficacy, Safety, And Tolerability Of Bococizumab (Pf-04950615), In Reducing The Occurrence Of Major Cardiovascular Events In High Risk Subjects
INTERVENTIONAL
Inicio: 29 de oct de 2013
ID: NCT01975389
Completado
Fase 3
ClinicalTrials.gov
A PHASE 3 RANDOMIZED, DOUBLE-BLIND STUDY OF PF-05280014 PLUS PACLITAXEL VERSUS TRASTUZUMAB PLUS PACLITAXEL FOR THE FIRST-LINE TREATMENT OF PATIENTS WITH HER2-POSITIVE METASTATIC BREAST CANCER
INTERVENTIONAL
Inicio: 24 de feb de 2014
ID: NCT01989676
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of AL001 in Individuals at Risk for or With Frontotemporal Dementia Due to Heterozygous Mutations in the Progranulin Gene
INTERVENTIONAL
Inicio: 23 de jul de 2020
ID: NCT04374136
Completado
ClinicalTrials.gov
An International Randomised Controlled Trial to Establish the Effects of Early Intensive Blood Pressure Lowering in Patients With Intracerebral Haemorrhage.
INTERVENTIONAL
Inicio: 1 de sept de 2008
ID: NCT00716079
Completado
Fase 4
ClinicalTrials.gov
A Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase IV Trial to Evaluate the Effect of Saxagliptin on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischaemic Stroke in Patients With Type 2 Diabetes
INTERVENTIONAL
Inicio: 1 de may de 2010
ID: NCT01107886
Completado
Fase 3
ClinicalTrials.gov
A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 and 200 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
INTERVENTIONAL
Inicio: 1 de mar de 2010
ID: NCT01072630
Completado
ClinicalTrials.gov
Dual-focus Survey with an Emphasis on Heated Humidification Systems
OBSERVATIONAL
Inicio: 1 de jun de 2024
ID: NCT06536972
Desconocido
ClinicalTrials.gov
MicrobiAr: Characterization and Follow-up of Microbiome and Health Indicators in Obese, Pre-Diabetes and Type 2 Diabetes Cohorts Undergoing a Plant-based Diet and Lifestyle Intervention
INTERVENTIONAL
Inicio: 30 de may de 2022
ID: NCT05372445
Reclutando
ClinicalTrials.gov
Longitudinal Early-onset Alzheimer's Disease Study Protocol
OBSERVATIONAL
Inicio: 30 de abr de 2018
ID: NCT03507257
Anterior
1
...
25
26
27
...
434
Siguiente
Filtros